News - Regenstrief Institute

Building access to the Regenstrief Institute is restricted through early 2021. More on our coronavirus precautions.

Filtering

June 24, 2019 • Expert Opinion, News

Can Deprescribing Drugs Linked to Cognitive Impairment Actually Reduce Risk of Dementia?

JAMA Internal Medicine commentary highlights opportunity to discover modifiable risk factors for dementia In a commentary published in JAMA Internal Medicine, three Regenstrief Institute research scientists write that while they and other researchers have identified a strong and consistent link between anticholinergic drugs and cognitive impairment from observational studies, randomized clinical trials represent the only […]

May 29, 2019 • Expert Opinion

IHS Modernization: Focus on the Patients, and the Data will Follow

By Gregory Schmidt, MD & Theresa Cullen, MD, MS Healthcare in America is a pairing of extremes. When ranked, the United States has some of the very best and the very worst healthcare metrics. Cancer survival remains the highest of any country, yet maternal deaths and infant deaths rank the worst of all developed nations. […]

Recent Influence

influence

Evaluating the link between medications and dementia: Regenstrief researcher provides consultation

Oct 07, 2020

Regenstrief Institute research scientist Noll Campbell, PharmD, MS recently contributed to a study that made national headlines and provided more evidence that anticholinergic medications are linked to cognitive decline.

More Info >

influence

Dr. Embi discusses using HIT in learning health systems during webinar.

The role of informatics and HIT in learning health systems

Oct 05, 2020

Regenstrief President and Chief Executive Officer Peter Embí, M.D., M.S., led a discussion as part of a Learning Health System Leaders Webinar Series put on by the Northwest Learning Health Systems Center of Excellence and K12.

More Info >

influence